Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipopolysaccharides | 8 | 2014 | 200 | 0.610 |
Why?
|
| Sepsis | 3 | 2010 | 76 | 0.510 |
Why?
|
| Escherichia coli Infections | 2 | 2012 | 39 | 0.500 |
Why?
|
| Neutrophils | 2 | 2012 | 124 | 0.480 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2014 | 58 | 0.470 |
Why?
|
| Papio | 1 | 2012 | 21 | 0.450 |
Why?
|
| Pan troglodytes | 1 | 2012 | 21 | 0.450 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 25 | 0.440 |
Why?
|
| Chemokine CXCL2 | 1 | 2012 | 9 | 0.440 |
Why?
|
| Chemokine CXCL1 | 1 | 2012 | 15 | 0.430 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 146 | 0.350 |
Why?
|
| Cell Movement | 2 | 2012 | 545 | 0.350 |
Why?
|
| Bacterial Capsules | 1 | 2007 | 6 | 0.320 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2007 | 12 | 0.320 |
Why?
|
| Signal Transduction | 3 | 2012 | 1802 | 0.320 |
Why?
|
| Antigens, Bacterial | 1 | 2007 | 129 | 0.290 |
Why?
|
| Immunity, Innate | 4 | 2014 | 135 | 0.260 |
Why?
|
| Mice, Knockout | 11 | 2014 | 897 | 0.250 |
Why?
|
| Escherichia coli | 1 | 2007 | 436 | 0.250 |
Why?
|
| Antigens, CD | 4 | 2010 | 116 | 0.250 |
Why?
|
| Mice | 14 | 2014 | 5668 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2009 | 325 | 0.220 |
Why?
|
| Animals | 17 | 2014 | 14307 | 0.190 |
Why?
|
| Inflammation | 4 | 2009 | 577 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 7 | 2014 | 649 | 0.170 |
Why?
|
| Shock, Septic | 2 | 2010 | 16 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 6 | 2014 | 1530 | 0.150 |
Why?
|
| Mice, Mutant Strains | 2 | 2012 | 78 | 0.130 |
Why?
|
| Intussusception | 1 | 2014 | 4 | 0.120 |
Why?
|
| Cytokines | 4 | 2012 | 569 | 0.120 |
Why?
|
| Gastrointestinal Motility | 1 | 2014 | 18 | 0.120 |
Why?
|
| Chlorides | 1 | 2014 | 52 | 0.120 |
Why?
|
| Terminology as Topic | 3 | 2002 | 32 | 0.120 |
Why?
|
| Macrophages | 3 | 2005 | 431 | 0.110 |
Why?
|
| Ape Diseases | 1 | 2012 | 4 | 0.110 |
Why?
|
| Monkey Diseases | 1 | 2012 | 6 | 0.110 |
Why?
|
| Genes, MHC Class II | 1 | 2012 | 20 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2012 | 44 | 0.110 |
Why?
|
| Antibodies | 2 | 2010 | 135 | 0.110 |
Why?
|
| Apoptosis | 3 | 2010 | 1317 | 0.110 |
Why?
|
| Species Specificity | 1 | 2012 | 233 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 608 | 0.110 |
Why?
|
| Chemokines | 1 | 2012 | 89 | 0.110 |
Why?
|
| Endotoxemia | 2 | 2009 | 5 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 968 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2009 | 322 | 0.090 |
Why?
|
| Membrane Glycoproteins | 3 | 2014 | 197 | 0.090 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2009 | 38 | 0.090 |
Why?
|
| Milk Proteins | 1 | 2009 | 28 | 0.090 |
Why?
|
| Peptidoglycan | 2 | 2009 | 7 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2010 | 179 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 182 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2009 | 85 | 0.080 |
Why?
|
| Legionella pneumophila | 1 | 2007 | 2 | 0.080 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2007 | 3 | 0.080 |
Why?
|
| Acanthamoeba | 1 | 2007 | 5 | 0.080 |
Why?
|
| Lipid A | 1 | 2007 | 7 | 0.080 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 35 | 0.080 |
Why?
|
| Animal Structures | 1 | 2007 | 14 | 0.080 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 66 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 92 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2007 | 156 | 0.070 |
Why?
|
| Mice, Inbred C3H | 4 | 2009 | 83 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2009 | 420 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2007 | 140 | 0.070 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2007 | 145 | 0.070 |
Why?
|
| Liver | 1 | 2009 | 447 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 528 | 0.070 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 135 | 0.070 |
Why?
|
| Gram-Negative Bacteria | 1 | 2005 | 22 | 0.070 |
Why?
|
| Leukocytes | 2 | 2002 | 68 | 0.070 |
Why?
|
| Substrate Specificity | 1 | 2005 | 186 | 0.070 |
Why?
|
| Lyme Disease | 1 | 2005 | 16 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 341 | 0.070 |
Why?
|
| Borrelia burgdorferi | 1 | 2005 | 17 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2004 | 55 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2006 | 210 | 0.060 |
Why?
|
| Ligands | 1 | 2005 | 317 | 0.060 |
Why?
|
| HMGB1 Protein | 1 | 2004 | 29 | 0.060 |
Why?
|
| Immunity, Mucosal | 1 | 2004 | 45 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2006 | 347 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2005 | 467 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2005 | 120 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 520 | 0.060 |
Why?
|
| Humans | 6 | 2012 | 34853 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 162 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 229 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2009 | 93 | 0.040 |
Why?
|
| Spleen | 2 | 2009 | 192 | 0.040 |
Why?
|
| Manganese Compounds | 1 | 2014 | 12 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 14 | 0.030 |
Why?
|
| Male | 5 | 2014 | 18870 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 143 | 0.030 |
Why?
|
| Toll-Like Receptors | 2 | 2005 | 47 | 0.030 |
Why?
|
| Cell Line | 2 | 2009 | 1289 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2009 | 1442 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2009 | 1152 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 1300 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2014 | 287 | 0.030 |
Why?
|
| Time Factors | 2 | 2006 | 1681 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 282 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2009 | 1 | 0.020 |
Why?
|
| Ligation | 1 | 2009 | 9 | 0.020 |
Why?
|
| Punctures | 1 | 2009 | 4 | 0.020 |
Why?
|
| Isoindoles | 1 | 2009 | 17 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2009 | 61 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 29 | 0.020 |
Why?
|
| Cecum | 1 | 2009 | 16 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2009 | 103 | 0.020 |
Why?
|
| Female | 4 | 2014 | 19873 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 68 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2009 | 23 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2009 | 69 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2009 | 107 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2009 | 39 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2009 | 64 | 0.020 |
Why?
|
| Imidazoles | 1 | 2009 | 124 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 165 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2007 | 6 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 423 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2007 | 17 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2007 | 22 | 0.020 |
Why?
|
| Heart Rate | 1 | 2009 | 248 | 0.020 |
Why?
|
| Culture Media | 1 | 2007 | 84 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 605 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 932 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2007 | 112 | 0.020 |
Why?
|
| Acute-Phase Reaction | 1 | 2006 | 2 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2007 | 392 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 26 | 0.020 |
Why?
|
| Nitrites | 1 | 2006 | 38 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1490 | 0.020 |
Why?
|
| Nitrates | 1 | 2006 | 35 | 0.020 |
Why?
|
| Gene Expression | 1 | 2009 | 639 | 0.020 |
Why?
|
| Biofilms | 1 | 2007 | 166 | 0.020 |
Why?
|
| Computational Biology | 1 | 2007 | 275 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2005 | 4 | 0.020 |
Why?
|
| Ionomycin | 1 | 2004 | 9 | 0.020 |
Why?
|
| COS Cells | 1 | 2004 | 62 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 424 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2004 | 43 | 0.020 |
Why?
|
| Arthritis, Experimental | 1 | 2004 | 5 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2004 | 77 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 48 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 97 | 0.020 |
Why?
|
| Streptococcus pyogenes | 1 | 2004 | 25 | 0.020 |
Why?
|
| Spermine | 1 | 2004 | 64 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 72 | 0.020 |
Why?
|
| Mutation | 1 | 2007 | 1023 | 0.010 |
Why?
|
| P-Selectin | 1 | 2002 | 5 | 0.010 |
Why?
|
| Microcirculation | 1 | 2002 | 39 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 396 | 0.010 |
Why?
|
| Goals | 1 | 2002 | 30 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 59 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 550 | 0.010 |
Why?
|
| Cell Communication | 1 | 2002 | 93 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 3261 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2002 | 107 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 306 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 984 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 310 | 0.010 |
Why?
|
| Skin | 1 | 2002 | 173 | 0.010 |
Why?
|
| Calcium | 1 | 2004 | 445 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 257 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 2128 | 0.010 |
Why?
|